What to know about FDA’s review of new Zyn advertising proposal
January 23, 2026 by apnews.com
What to know about FDA’s review of new Zyn advertising proposal
The FDA is considering approving Phillip Morris International's Zyn pouches as a less harmful alternative for smokers. FDA experts are inclined towards approval, though concerns about underage use and marketing efficacy remain. Zyn, with various flavors, is a fast-growing product in the tobacco industry. Phillip Morris aims to promote Zyn as reducing risks associated with smoking-related diseases. Evidence supports Zyn's potential health benefits, but long-term studies and impact on smokers switching are lacking. FDA must also assess potential harm to young people despite low teenage use of nicotine pouches.
January 21, 2026 by 13wham.com
"A distinction without a difference" Hochul admin proposes tax on nicotine pouches
Governor Hochul's FY2027 budget proposes taxing nicotine pouches like Zyn under the tobacco product…
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
